FDA Taps NIH Veteran Corrigan-Curay To Lead Medical Policy Office
Executive Summary
Jacqueline Corrigan-Curay joins from the National Heart, Lung and Blood Institute, where she worked on clinical trial initiatives and served as an NIH representative on FDA’s Drug Safety Oversight Board.
You may also be interested in...
Cavazzoni Begins Putting Her Mark On FDA Drug Center With New Principal Deputy Position
Jacqueline Corrigan-Curay brings a broad array of policy experience, from trial design to real-world evidence to supply chain and post-market surveillance, to the CDER principal deputy director role, though US FDA is not yet able to articulate exactly what her promotion will entail.
Chief Scientist At US FDA Is Hinton As Borio Moves To White House
Luciana Borio is detailed to National Security Council; FDA promotes Denise Hinton to acting chief scientist.
Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director
Peter Stein, a leader in diabetes drug development programs, joins FDA as a new administration is about to come in; he fills one of 676 CDER vacancies.